RESCON SUMMIT · US EDITIONS ARCHIVE · 2025
Past edition / 05–06 November 2025

RESCON
San Francisco.

A look back at RESCON Summit USA 2025 — bringing together experts in inhalation and respiratory drug delivery, connected devices and emerging therapeutic technologies.

This page is an archive of the 2025 event. For upcoming RESCON participation, use the current registration and sponsorship pages.

RESCON SUMMIT / USA
2025.
San Francisco
05–06 November 2025California · United States
2025US edition
20+Speakers featured
80+Industry leaders highlighted
San FranciscoCalifornia, USA
About the 2025 edition

Where respiratory innovation met industry.

RESCON Summit 2025 brought global leaders from pharmaceutical, biotechnology and device companies to San Francisco on 5–6 November to discuss advances in inhalation and respiratory drug delivery.

The programme explored the development pathway from inhaled formulations and nanocarriers to dry-powder devices, soft mist technologies, connected health, regulatory strategy and commercial collaboration.

Beyond the presentations, the event created space for technical discussion, networking and partnerships across the respiratory value chain.

The RESCON experience
01Meet top experts
02Learn from speakers
03Expand your network
04Enjoy the conference
Scientific focus / 2025

The key practical points.

Explore the ten scientific and technical themes from the original 2025 event overview.

01

Next-Generation Inhalation & Nasal Delivery Platforms

Gain exposure to the latest in non-invasive drug delivery systems, including soft mist inhalers, nasal powders, and epithelial delivery routes, aiming to eliminate syringes and expand therapeutic access.

02

Formulation Innovation: From Nanocarriers to Combination Therapies

Explore formulation strategies for inhalable nanocarriers, microparticles, and combination products, optimizing lung targeting, therapeutic efficacy, and stability.

03

Dry Powder Inhalers: Performance, Usability & Testing

Understand how engineering design, realistic testing models, and patient-centric considerations impact the real-world performance and acceptance of DPIs.

04

Predictive Preclinical Models & Translational Development

Discover integrated approaches combining human ex vivo and in vivo data to enhance the safety, efficacy, and predictivity of respiratory drug development.

05

Digital Health Integration & Smart Device Innovation

See how digital inhalers, remote monitoring, and connected health platforms are shaping the future of adherence tracking, clinical insights, and patient engagement.

06

Regulatory Strategy for Inhaled Combination Products

Navigate FDA and EMA pathways for complex inhaled combination products, including considerations for nebulized gene therapies and evolving environmental standards.

07

Sustainable Design & Green Propellant Transition

Learn how the transition to low global warming potential (GWP) propellants and eco-conscious design is reshaping the respiratory device landscape.

08

Health Economics & Real-World Evidence in Respiratory Disease

Analyze how open and closed claims data, cost-of-illness studies, and economic modeling inform access strategies for rare and chronic respiratory conditions.

09

Patient-Centric Innovation in Inhaled Therapeutics

Examine how usability studies, connected technologies, and human factors research drive more intuitive and effective inhalation therapies tailored to patient needs.

10

Emerging Trends in Inhaled Biologics & Airway Remodeling

Understand scientific advancements in airway mucosal remodeling, aerosol therapy, and the potential of inhaled biologics and ions for systemic and localized effects

These are archived themes from the 2025 programme — not the current RESCON agenda.View the official 2025 agenda ↗
Beyond the programme

Ideas, people and connections.

Scientific exchange was complemented by networking, panel discussions and time with the wider respiratory community.

01 / EVENT FEATURE20+ conference sessions
02 / EVENT FEATUREPre-conference cocktail reception
03 / EVENT FEATUREPanel discussions
04 / EVENT FEATURESpeed networking
05 / EVENT FEATUREExhibition hall
06 / EVENT FEATUREGala dinner with live music
2025 event video

Revisit San Francisco.

Watch the event highlights, then browse the photo report for a closer look at the people and conversations behind RESCON Summit 2025.

Watch the 2025 video ↗
View the photo report ↗
Who the event brought together

A cross-industry audience.

Senior decision-makers and technical specialists across pharmaceutical, respiratory device and supporting technology sectors.

01 / EXPERTISE

Device & engineering

Device development and engineering; inhalation devices; new delivery technologies; medical devices.

02 / EXPERTISE

Pharma & formulation

Respiratory R&D; drug development; inhaled formulation science; respiratory pharmacology.

03 / EXPERTISE

Quality & regulatory

Respiratory regulations; particle characterisation; process development; packaging.

04 / EXPERTISE

Leadership & partnering

Board members; CEOs; VPs; directors; business development; outsourcing; commercial functions.

Scientific contributors

Featured 2025 speakers.

A selection of the contributors from the San Francisco programme, spanning pharma, device development, manufacturing and respiratory science.

2025 SPEAKER / 01Ulf KruegerChief Executive Officer · PULMOTREE
2025 SPEAKER / 02Stephen PhamSVP, Product Development · Avalyn Pharma
2025 SPEAKER / 03Bernhard MüllingerGeneral Manager & COO · Resyca
2025 SPEAKER / 04Sarah MolloPrincipal Consultant · Suttons Creek
2025 SPEAKER / 05Irene RossiRespiratory Sciences Expert · Harro Höfliger
2025 SPEAKER / 06Jim FinkChief Science Officer · Aerogen Pharma
2025 SPEAKER / 07Dan BeachSr. Applications Team Lead · Malvern Panalytical
2025 SPEAKER / 08Armin BraunDivision Director · Fraunhofer ITEM

Selected names shown. Explore the original speakers page for the complete roster.

View all 2025 speakers ↗
The next chapter

Be part of what's next at RESCON.

Our past editions are part of an ongoing conversation across inhalation and respiratory drug delivery. Explore the opportunities to join the next summit as a delegate or partner.